Shield Therapeutics (STX) RNS Announcements

Add to Alert list
Date Time Source Announcement
23 Feb 2022 02:01 PM
RNS
Price Monitoring Extension
23 Feb 2022 11:05 AM
RNS
Second Price Monitoring Extn
23 Feb 2022 11:00 AM
RNS
Price Monitoring Extension
18 Feb 2022 02:06 PM
RNS
Second Price Monitoring Extn
18 Feb 2022 02:00 PM
RNS
Price Monitoring Extension
17 Feb 2022 09:05 AM
RNS
Second Price Monitoring Extn
17 Feb 2022 09:00 AM
RNS
Price Monitoring Extension
17 Feb 2022 07:00 AM
RNS
Full Year Trading Update
04 Feb 2022 07:00 AM
RNS
KOL Investor Event on Iron Deficiency
07 Jan 2022 07:00 AM
RNS
Investor Presentation
05 Jan 2022 07:00 AM
RNS
Licence Agreement in Canada for Accrufer®
30 Dec 2021 09:06 AM
RNS
Second Price Monitoring Extn
30 Dec 2021 09:00 AM
RNS
Price Monitoring Extension
29 Dec 2021 11:05 AM
RNS
Second Price Monitoring Extn
29 Dec 2021 11:00 AM
RNS
Price Monitoring Extension
16 Dec 2021 11:05 AM
RNS
Second Price Monitoring Extn
16 Dec 2021 11:00 AM
RNS
Price Monitoring Extension
16 Dec 2021 07:00 AM
RNS
Patient Access Expands for Accrufer®
07 Oct 2021 09:45 AM
EQS
Shield Therapeutics (STX) Life Sciences Investo...
30 Sep 2021 05:30 PM
RNS
Block Listing 6 Monthly Return
27 Sep 2021 07:00 AM
RNS
Jose A. Menoyo Appointed as Chief Medical Officer
21 Sep 2021 07:00 AM
RNS
Investor presentation
23 Aug 2021 07:00 AM
RNS
PDMR Transaction Notification
20 Aug 2021 11:08 AM
EQS
Shield Therapeutics (STX) - Focused on US marke...
17 Aug 2021 07:00 AM
RNS
Half-year Report
12 Aug 2021 07:25 AM
EQS
Hardman & Co Video Event | Shield Therapeut...
12 Aug 2021 07:00 AM
RNS
Licence agreement secured in Republic of Korea
11 Aug 2021 07:00 AM
RNS
Notice of Results
09 Aug 2021 07:00 AM
RNS
AEGIS-CKD study results published in AJKD
04 Aug 2021 04:41 PM
RNS
Second Price Monitoring Extn
04 Aug 2021 04:35 PM
RNS
Price Monitoring Extension
04 Aug 2021 02:05 PM
RNS
Second Price Monitoring Extn
04 Aug 2021 02:00 PM
RNS
Price Monitoring Extension
24 Jun 2021 07:00 AM
RNS
US launch of Accrufer® confirmed for July 1, 2021
23 Jun 2021 04:40 PM
RNS
Second Price Monitoring Extn
23 Jun 2021 04:35 PM
RNS
Price Monitoring Extension
21 Jun 2021 01:35 PM
RNS
Investor presentation
18 Jun 2021 07:00 AM
RNS
Directorate Change
17 Jun 2021 02:30 PM
RNS
Results of 2021 Annual General Meeting
15 Jun 2021 06:15 PM
RNS
Grant of share options to the CEO
28 May 2021 07:00 AM
RNS
Appointment of new Chief Executive Officer
28 May 2021 07:00 AM
RNS
Total Voting Rights
26 May 2021 10:35 AM
EQS
Shield Therapeutics (STX): Accrufer launch on s...
21 May 2021 07:00 AM
RNS
US update
18 May 2021 07:00 AM
RNS
AEGIS-H2H study results published in IBD
17 May 2021 07:00 AM
RNS
Commencement of trading on the OTCQX Best Market
13 May 2021 03:00 PM
RNS
2020 Annual Report and 2021 AGM Notice
10 May 2021 07:00 AM
RNS
Appointment of Two Non-Executive Directors
06 May 2021 01:44 PM
RNS
Total Voting Rights Update
29 Apr 2021 07:00 AM
RNS
Preliminary Results
UK 100

Latest directors dealings